How do different microglial subtypes (DAM vs inflammatory vs homeostatic) transition between states in neurodegeneration?
PARTIALLY ADDRESSED
The debate framework mentioned multiple microglial subtypes but no analysis was provided on the molecular triggers, temporal dynamics, or reversibility of these state transitions. Understanding these mechanisms is critical for timing therapeutic interventions.
Source: Debate session sess_SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402 (Analysis: SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402)
Landscape Summary:
How do different microglial subtypes (DAM vs inflammatory vs homeostatic) transition between states in neurodegeneration? is a 0.87 priority gap in neurodegeneration.
It has 0 linked hypotheses with average composite score 0.000.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
How do different microglial subtypes (DAM vs inflammatory vs homeostatic) transition between states in neurodegeneration? — INVOKE-2 (completed)